Pioneering immunologist, Carl June, discusses his work on CAR T cell therapy, including its origins in HIV treatment, effectiveness in treating B cell malignancies, challenges with cytokine storms, and future prospects for cancer treatment advancements.

Dr. Carl June discusses his pioneering work in CAR T therapy, his journey into T cell immunology, the challenges in treating solid tumors, and the potential solutions in cancer treatment.

Dr. Carl June and Dr. Philipp Rommel discuss ex vivo T cell engineering for cancer and HIV therapies. They cover topics like m6A RNA modification in immune responses and synthetic Notch CAR T cells targeting solid tumors. The podcast also explores challenges in translating T cell therapy breakthroughs and immunotherapy strategies for cancer interception.